Menu
Content/Inhalt
Home
|
Careers
|
Contact us
Search
Welcome
History
Social responsibility
Our companies
Debiopharm Group
Debiopharm S.A.
Debio R.P. S.A.
Debioclinic S.A.
Debiovision Inc.
Debioinnovation S.A.
Business Model
Strengths
Development capabilites
Preclinical
Clinical
Manufacturing
Regulatory
Innovative drug delivery and formulation
Partnering
Licensing-in
Licensing-out
Partners
Pipeline
Commercial Products
Eloxatin®
Decapeptyl®
News & Events
Press Releases
Awards
Publications
Conferences
News
02.09.2008
Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate For Cancer Treatment
21.08.2008
Doctor Manel Esteller Receives the Debiopharm Life Sciences Award For his Outstanding Research in Epigenetic Oncology
Home
News & Events
Press Releases
PRESS RELEASES
Order
Date asc
Date desc
Title asc
Title desc
Ordering
Display #
5
10
15
20
25
30
50
Date
Item Title
02-Sep-2008
Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate For Cancer Treatment
21-Aug-2008
Doctor Manel Esteller Receives the Debiopharm Life Sciences Award For his Outstanding Research in Epigenetic Oncology
19-Jun-2008
Le "Prix Debiopharm/Valais pour les Sciences de la Vie" honore un chimiste valaisan pour son procédé électrochimique novateur
27-Feb-2008
Debiopharm and EPFL Establish An Oncology Chair
10-Dec-2007
Debiopharm favorise l'Esprit d'Entreprise en Valais
15-Nov-2007
Chinese Scientist Receives the Debiopharm-CCRF China Award
07-Oct-2007
Japanese Scientists Receive JCA-Mauvernay Award 2007
10-Sep-2007
Debiopharm Receives cGMP Certification for QC of Drug Products
29-Aug-2007
Debiopharm Life Sciences Award in Neurosciences Goes to Nusser
11-Mar-2007
Preclinical update - Debio-0512 therapeutic vaccine for the treatment of chronic and acute inflammatory conditions - Proof of concept in mice transgenic for human TNFá
19-Nov-2006
2006 Mauvernay Research Excellence Award
15-Oct-2006
Debiopharm and Cambridge Antibody Technology enter into an exclusive agreement to develop and market SC-1 for gastric carcinomas
10-Oct-2006
Debiopharm and EPFL honour Dr Eduard Batlle with the "Debiopharm Life Sciences Award"
01-Oct-2006
The Japanese Cancer Association (JCA) and Debiopharm honour Professors Masanori Hatakeyama and Johji Inazawa with the 2006 JCA-Mauvernay Award
20-Sep-2006
Debiopharm granted European Orphan Drugs Status for Debio-0513 (PTR-262) for Myasthenia Gravis
21-May-2006
Debiopharm and TcLand sign R&D and exclusive license option for the development of sc28AT autoimmune diseases and transplantation
01-May-2006
Debiopharm et la Haute Ecole Valaisanne collaborent pour développer les médicaments de demain
19-Dec-2005
Debiopharm and Dyax Corp. restructure development agreement for Depelestat (EPI-hNE4 or DX-890) in pulmonary disorders
02-Nov-2005
Debiopharm and EPFL launch the "Debiopharm Life Sciences Award"
19-Sep-2005
The Japanese Cancer Association (JCA) and Debiopharm present the inaugural 2005 JCA-Mauvernay award in Japan
< Prev
1
2
3
Next >
Results 1 - 20 of 45
Triptorelin – Trelstar® – Decapeptyl® - Pamorelin®
( 8 items )
Debio 8609 Sanvar®
( 12 items )
Debio 025
( 5 items )
Debio 9902 - ZT-1
( 8 items )
Debio 0614 (istaroxime)
( 2 items )
Debio 0507
( 3 items )
Debio 0719
( 1 items )
Debio 0824
( 1 items )
Debio 0617
( 1 items )
Oxaliplatin – Eloxatin® – Elplat®
( 10 items )
Moapar® - Salvacyl®
( 3 items )